Learning Objectives:

1.  Understand new therapeutic options for Lennox-Gastaut and Dravet syndromes.

2.  Review the role of anti-sense oligonucleotides as a treatment for rare neurologic diseases.

3.  Understand the utility of currently available genetic testing for neurologic disease.

Session date: 
10/17/2023 - 8:00am to 9:00am CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Lubov Romantseva, MD